Showing 61 - 80 results of 132 for search 'Research to Prevent Blindness', query time: 0.08s Refine Results
  1. 61
  2. 62
  3. 63
  4. 64
  5. 65

    Association of Depression/Anxiety Symptoms with Neck Pain: A Systematic Review and Meta-Analysis of Literature in China by Fushui Liu, Ting Fang, Fanyuan Zhou, Meimei Zhao, Mei Chen, Jianyu You, Yuli Jin, Jinmei Xie, Zhongyong Liu

    Published 2018-01-01
    “…Controlled trials incorporating NP patients with anxiety/depression versus healthy people were contained. Two researchers screened each article and extracted data, respectively, and blinded to the findings of each other. …”
    Get full text
    Article
  6. 66
  7. 67
  8. 68

    Impact of polygeNic risk score for glaucoma on psycHosocial ouTcomes (INSiGHT) study protocol. by Giorgina Maxwell, Robert Allen, Simone Kelley, Lucinda Hodge, Georgina L Hollitt, Mathias Seviiri, Daniel Thomson, Joshua Schmidt, Jamie E Craig, Sarah Cohen-Woods, Emmanuelle Souzeau

    Published 2024-01-01
    “…Potential clinical applications include identification of high-risk individuals, resulting in earlier diagnosis and treatment to prevent glaucoma blindness, and adjusted monitoring for low-risk individuals. …”
    Get full text
    Article
  9. 69
  10. 70

    Association of sildenafil use with age-related macular degeneration: a retrospective cohort study by Nicola Jaime Adderley, Krishnarajah Nirantharakumar, Anuradhaa Subramanian, Alastair K Denniston, Wen Hwa Lee, Ji Eun Diana Han, Jesse Coker

    Published 2024-04-01
    “…Objective Despite significant advances in clinical care and understanding of the underlying pathophysiology, age-related macular degeneration (AMD)—a major cause of global blindness—lacks effective treatment to prevent the irreversible degeneration of photoreceptors leading to central vision loss. …”
    Get full text
    Article
  11. 71
  12. 72

    Mechanisms of Rhodopsin-Related Inherited Retinal Degeneration and Pharmacological Treatment Strategies by Maria Azam, Beata Jastrzebska

    Published 2025-01-01
    “…These mechanisms, however, often fail to prevent photoreceptor cell degradation and instead contribute to cell death under certain conditions. …”
    Get full text
    Article
  13. 73
  14. 74

    Conservative treatment for cataract: state-of-the-art by S.Yu. Petrov, I.V. Kozlova, R.P. Poleva

    Published 2019-11-01
    “…&nbsp;Poleva</b><br> </p> <p> <b>Scientific Research Institute of Eye Diseases, Moscow, Russian Federation</b> </p> <p> <br> </p> <p> <i>Cataract is one of the leading causes of blindness worldwide and an important medical social issue in many countries. …”
    Get full text
    Article
  15. 75

    What Is New in Glaucoma: From Treatment to Biological Perspectives by Raffaele Nuzzi, Paola Marolo, Alessia Nuzzi

    Published 2021-01-01
    “…Glaucoma is a chronic silent disease and an irreversible cause of blindness worldwide. Research has made many efforts to improve disease control and especially to anticipate both early diagnosis and treatment of advanced stages of glaucoma. …”
    Get full text
    Article
  16. 76

    Role of ARMS2/HTRA1 risk alleles in the pathogenesis of neovascular age-related macular degeneration by Yang Pan, Takeshi Iwata

    Published 2024-12-01
    “…In this comprehensive review, we provide an overview of the role played by ARMS2/HTRA1 risk alleles in neovascular AMD pathogenesis, covering GWAS, in vitro studies, and animal models, shedding light on their underlying molecular genetic mechanisms. Further extensive research is also imperative, including confirmation of these findings, identifying novel treatment targets, and advancing primary and secondary prevention strategies for AMD.…”
    Get full text
    Article
  17. 77

    The fundus changes in pathological myopia by Markosyan G.A., Tarutta E.P, Tarasova N.A., Maksimova M.V.

    Published 2019-07-01
    “…Maksimova — Researcher of the Department of Refractive Pathology, ORCID iD 0000-0002-3749-3668.…”
    Get full text
    Article
  18. 78

    Pharmacotherapy for AMD: state-of-the-art by I.A. Koroleva, A.A. Gvetadze, T.B. Romanova

    Published 2019-07-01
    “…Agents which prevent neovascularization by inhibiting vascular endothelial growth factor (VEGF) are currently used to manage this rapidly progressing type of AMD. …”
    Get full text
    Article
  19. 79
  20. 80

    Early diagnosis and the effect of treatment compliance on the prognosis and progression of glaucomatous optic neuropathy by S.V. Diordiychuk, A.V. Kuroyedov, N.E. Fomin, O.V. Gapon’ko, V.V. Gorodnichiy, I.V. Kondrakova, N.M. Sol’nov

    Published 2021-03-01
    “…The described disease course has demonstrated that several factors affect the prognosis and development of a chronic progressive neurodegenerative disorder, which results in irreversible blindness. These factors include early diagnosis, accessible and effective screening system, rational management strategy that implies the drug change to prevent the reduction in therapeutic effect, and patient adherence to treatment that involves explaining the causes and characteristics of disease cours e, potential complications with recommendation noncompliance, and a professional work a doctor with a patient.…”
    Get full text
    Article